Resuscitation with the hemoglobin-based oxygen carrier, HBOC-201, in a swine model of severe uncontrolled hemorrhage and traumatic brain injury

Shock. 2009 Jan;31(1):64-79. doi: 10.1097/SHK.0b013e3181778dc3.

Abstract

The purpose of this investigation was to compare the effects of initial resuscitation with HBOC-201 to that of lactated Ringer (LR) solution in the setting of uncontrolled hemorrhage and traumatic brain injury (TBI). Anesthetized immature swine underwent fluid-percussion TBI and liver laceration. During a 75-min "prehospital phase," the animals were resuscitated with HBOC-201, LR solution, or nothing (NON). Upon "hospital arrival," the animals were provided blood and 0.9% NaCl as needed, and the liver injury was repaired. Surviving animals were killed 6 h after injury. Brain tissue was processed for blood flow, and gross, light microscopic, and immunohistochemical analyses. Mean TBI force (2.6 +/- 0.6 atm) and blood loss (64.4 +/- 3.4 mL/kg) were similar between groups. Six-hour survival was significantly greater in HBOC-201 (8 of 13 [62%]) versus LR solution (1 of 11 [9%]) and NON (1 of 8 [3%]) animals (P < 0.02). Mean arterial pressures, cardiac indices, cerebral perfusion pressures, and brain tissue oxygen tension were significantly greater, and lactate and base deficit were lower in HBOC-201 as compared with LR solution animals. Blood transfusion requirements were reduced in HBOC-201 (3.6 +/- 0.6 mL/kg per survival hour) as compared to 7.1 +/- 1.2 mL/kg per survival hour. Severity of subarachnoid and intraparenchymal hemorrhages was statistically greater in LR solution-treated animals, but these differences were not likely to be clinically significant. There were no differences in glial fibrillary acidic protein and microtubule-associated protein 2. In this model of combined uncontrolled hemorrhage and TBI, initial resuscitation with HBOC-201 resulted in significant improvements in survival and systemic and cerebrovascular physiological parameters, as well as a reduction in transfusion requirements.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Blood Flow Velocity / drug effects
  • Blood Pressure / drug effects
  • Blood Substitutes / pharmacology*
  • Brain / blood supply
  • Brain / pathology
  • Brain / physiopathology
  • Brain Injuries / pathology
  • Brain Injuries / physiopathology
  • Brain Injuries / therapy*
  • Disease Models, Animal
  • Female
  • Hemoglobins / pharmacology*
  • Hemorrhage / pathology
  • Hemorrhage / physiopathology
  • Hemorrhage / therapy*
  • Humans
  • Isotonic Solutions / pharmacology
  • Liver / blood supply
  • Liver / injuries
  • Liver / pathology
  • Liver / physiopathology
  • Liver Diseases / pathology
  • Liver Diseases / physiopathology
  • Resuscitation*
  • Ringer's Lactate
  • Swine

Substances

  • Blood Substitutes
  • Hemoglobins
  • Isotonic Solutions
  • Ringer's Lactate
  • HBOC 201